news 6 20page EN 2 - Τράπεζα...

Click here to load reader

  • date post

    27-Mar-2018
  • Category

    Documents

  • view

    216
  • download

    2

Embed Size (px)

Transcript of news 6 20page EN 2 - Τράπεζα...

  • NEWS 06www.biohellenika.gr

    Biohellenika's laboratories, in palsy and autism is a promising

    collaboration with University and target for autologous stem cell

    private sector clinics in Greece and therapy.

    neighboring countries are presently In the case of cerebral palsy, it is supporting several stem cell clinical presently widely accepted that trials that are under development. autologous cord blood stem cell

    Ischemic brain injury that has been administration may be the only

    implicated in ailments, like cerebral hope for cure. n page 04 n page 06

    July 2010

    Athanasios is the fourth child in the family and his parents decided to store his umbilical

    cord blood stem cells in order to protect the future health of their growing family.

    Athanasios was born overweight and therefore his mother had a difficult labor. During

    delivery his brain became hypoxic for several minutes because the middle cerebral artery

    was clotted. Athanasios had early indications of cerebral palsy and his family did

    everything possible to cure him.

    03

    09

    10

    08

    11

    12

    13

    16

    n page 07

    Biohellenika's laboratories support autologous stem cell therapy CLINICAL TRIALS

    BIOHELLENIKA and TAK-EIE Laboratories supported the first stem cell therapy for autism in Greece

    The first autism stem cell therapy

    was possible in Greece with a

    collaboration of specialized doctors

    and the laboratory support of

    Biohellenika TAK EIE.

    THE SECOND CEREBRAL PALSY CHILD WHO HAS STORED UMBILICAL CORD BLOOD STEM CELLS IN BIOHELLENIKA HAS BEEN TREATED AT DUKE UNIVERSITY HEMATOLOGY CLINIC

    Biohellenika's Laboratories in Athens (TAKE EIE) are the first ministry of health licensed family cord blood bank in Greece

    Stem Cells and Hair Loss (Alopecia)

    New data for the use of cord blood placenta derived stem cells

    Biohellenika's Services

    The Advantages of Biohellenika

    Stem cells for type I diabetes therapy

    Non-haematological uses of cord blood stem cells

    Potential role of dental stem cells in the cellular therapy of cerebral ischemia

  • NEWS02

    Biohellenika is the first company in Greece which operates under the guidelines of ISO 15189, and is accredited as medical laboratory on 08/02/2008 with the 410/8/2/2008 accreditation certificate by the National Accreditation Forum S.A. (ESYD), granted for procedures followed and quality testing of umbilical cord blood during the collection of stem cells. With this certification, Biohellenika is accredited according to ISO 15189:2007, special for medical laboratories, for nucleated cell measurement, hematopoietic stem cell viability and sterility testing, including aerobic, anaerobic bacteria and fungi. This certificate is valid until 2012 as long as the facility's operations comply with the above guidelines during regular ESYD inspections.

    The Accreditation is recently expanded to the Molecular Diagnostics Laboratory that is established in Biohellenika's facilities and provides genetic analysis of inherited diseases, cardiovascular diseases, infertility and HPV tests.

    The National Accreditation Forum (ESYD) is a full member of the International Laboratory Accreditation Cooperation (ILAC) since 2004, of the European Cooperation for Accreditation EA since 2005, and of the International Accreditation Forum (IAF-MRA) since 2006.

    The international identity of ESYD gives the perspective of the parity and mutual recognition of accreditation between countries. Today Biohellenika is the first company in Greece whose laboratories are accredited by a national independent organization for measurements and quality control procedures followed during stem cell collection from umbilical cord blood.

    Biohellika currently is being evaluated for the international accreditation by the American Association of Blood Banks (AABB).

    03NEWS

    he laboratories of TAK EIE, a joint venture

    between Hellenic National Research

    Foundation and Biohellenika Biotechnology Applications S.A. is the first cord blood bank

    that Greek Ministry of Health administered a license.

    TAK EIE laboratories are serving all samples Biohellenika

    collects from Athens, southern Greece and Aegean

    islands. Biohellenika owns two laboratories in Greece,

    one in Athens (TAKEIE) and one in Thessaloniki, in order

    to improve the stored stem cell quality by minimizing

    the time gap between birth and stem cell processing.

    The licensing of its laboratories will enable Biohellenika

    to establish medical applications locally and abroad, in

    collaboration with scientists, medical doctors and

    parents, who trusted the name Biohellenika in these

    countries and have already banked the precious stem

    cells of their children in Biohellenika.

    NEW SERVICEBiohellenika has developed the technology and now

    provides the parents the storage of mesenchymal

    stem cells from the total length of the umbilical

    cord. With this method, all mesenchymal stem cells

    of the umbilical cord are collected and stored and

    therefore no cell cultures will be needed in the

    future, which would be applied if the number of

    stem cells is not enough, with an extra cost.

    This service is added to the classical collection of

    umbilical cord, by the puncture of the umbilical cord

    vein and to the placenta drainage and provides the

    family all the possible hematopoietic and

    mesenchymal stem cells that can be collected

    during labor. Given that, stem cells of umbilical cord

    and placenta are superior in quality than any other

    source of stem cells, Biohellenika provides the child

    and the family, the greatest possible quantity and

    quality of stem cells.

    DYNAMIC EXPANSION OF BIOHELLENIKA TO NEIGBORING COYNTRIES Biohellenika expanded its activities to Romania,

    through Biohellenica Ro., to Bulgaria through

    Biohellenika Bg. and Servia through Beo Stem. A lot

    of parents from the neighboring countries select

    Biohellenika to store their children's stem cells.

    Biohellenika Bulgaria announced its opening in thBulgaria with a press conference on 13 of May and

    participated to the Annual Meeting of Bulgaria

    Obstetrics-Gynecology Society. The Meeting took

    place in Promorie, from 24-26 Jun 2010, and Dr.

    Kouzi-Koliakou, the scientific director of

    Biohellenika, presented a topic about Stem cells

    applications and the new perspectives.

    Also, Dr. Koliakou on 14/5/2010 represented

    Biohellenika in the Annual Romanian Dentists

    meeting in Brasov, where she presented The dental

    pulp stem cells and its applications.

    Biohellenika S.A. is the first Accredited by ESYD (National Accreditation Forum) Stem Cell Cryopreservation Company

    Biohellenika's Laboratories in Athens (TAKE EIE)ARE THE FIRST MINISTRY OF HEALTH LICENSED FAMILY CORD BLOOD BANK IN GREECE

    . 410

    ACCREDITATION CERTIFICATE

    The Hellenic Accreditation System S.A. (ESYD), as the national accreditation body ofGreece, in accordance with the Law 3066/2002,

    ACCREDITS

    the

    Laboratoryof the

    BIOHELLENIKA S.A.

    in Thessaloniki, Greece

    Athens, February 8, 2008

    . Papaioannou Chairman of ESYD

    Hellenic Accreditation System S.A.

    65, Georgikis Scholis Avenue, 57001 Thessaloniki

    ZEDA building

    Tel.: 0030 2310.474.282, 2310.474.284, Fax: 0030 2310.474.285

    E-mail: info@biohellenika.gr, www.biohellenika.gr

    NEWSQuarterly publication of Biohellenika

    Nr 06

    Biohellenika S.A. is responsible for the published material in this issue.

    All rights reserved. No part of this issue may be reproduced without permission of the publisher.

    the biggest greek stem cell cryopreservation institution

    Biohe enikaBIOTECHNOLOGY COMPANY

  • NEWS02

    Biohellenika is the first company in Greece which operates under the guidelines of ISO 15189, and is accredited as medical laboratory on 08/02/2008 with the 410/8/2/2008 accreditation certificate by the National Accreditation Forum S.A. (ESYD), granted for procedures followed and quality testing of umbilical cord blood during the collection of stem cells. With this certification, Biohellenika is accredited according to ISO 15189:2007, special for medical laboratories, for nucleated cell measurement, hematopoietic stem cell viability and sterility testing, including aerobic, anaerobic bacteria and fungi. This certificate is valid until 2012 as long as the facility's operations comply with the above guidelines during regular ESYD inspections.

    The Accreditation is recently expanded to the Molecular Diagnostics Laboratory that is established in Biohellenika's facilities and provides genetic analysis of inherited diseases, cardiovascular diseases, infertility and HPV tests.

    The National Accreditation Forum (ESYD) is a full member of the International Laboratory Accreditation Cooperation (ILAC) since 2004, of the European Cooperation for Accreditation EA since 2005, and of the International Accreditation Forum (IAF-MRA) since 2006.

    The international identity of ESYD gives the perspective of the parity and mutual recognition of accreditation between countries. Today Biohellenika is the first company in Greece whose laboratories are accredited by a national independent organization for measurements and quality control procedures followed during stem cell collection from umbilical cord blood.

    Biohellika currently is being evaluated for the international accreditation by the American Association of Blood Banks (AABB).

    03N